Wells Fargo & Company Has Lowered Expectations for Crescent Capital BDC (NASDAQ:CCAP) Stock Price

Crescent Capital BDC (NASDAQ:CCAP) had its price objective lowered by investment analysts at Wells Fargo & Company from $14.00 to $13.00 in a report released on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target would suggest a potential upside of 2.69% from the company’s previous close.

Other equities analysts have also issued research reports about the company. Oppenheimer lowered their target price on Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating on the stock in a research note on Friday, November 14th. Keefe, Bruyette & Woods cut their target price on Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a research note on Friday, November 14th. Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 10th. Finally, Wall Street Zen upgraded Crescent Capital BDC from a “sell” rating to a “hold” rating in a research report on Saturday, January 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $16.13.

Crescent Capital BDC Stock Performance

CCAP opened at $12.66 on Friday. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 1.23. Crescent Capital BDC has a 12-month low of $12.62 and a 12-month high of $18.57. The business has a 50 day moving average of $14.19 and a 200-day moving average of $14.49. The stock has a market cap of $467.41 million, a price-to-earnings ratio of 13.47 and a beta of 0.55.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.44 by $0.01. Crescent Capital BDC had a return on equity of 9.27% and a net margin of 20.64%.The business had revenue of $40.80 million for the quarter, compared to analysts’ expectations of $39.83 million. On average, equities research analysts expect that Crescent Capital BDC will post 2.09 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Invesco Ltd. grew its position in shares of Crescent Capital BDC by 1,504.9% in the 4th quarter. Invesco Ltd. now owns 659,696 shares of the company’s stock valued at $9,269,000 after buying an additional 618,590 shares during the last quarter. North Ground Capital lifted its stake in shares of Crescent Capital BDC by 99.8% in the fourth quarter. North Ground Capital now owns 835,312 shares of the company’s stock worth $11,736,000 after acquiring an additional 417,312 shares during the period. Focus Partners Wealth bought a new stake in Crescent Capital BDC in the fourth quarter valued at approximately $5,476,000. Closed End Fund Advisors Inc. bought a new stake in Crescent Capital BDC in the fourth quarter valued at approximately $3,166,000. Finally, Alpine Global Management LLC acquired a new stake in Crescent Capital BDC during the 3rd quarter valued at approximately $3,137,000. 49.46% of the stock is owned by institutional investors.

Crescent Capital BDC News Roundup

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Q4 results slightly beat expectations — EPS of $0.45 topped consensus by $0.01 and revenue modestly beat estimates; management highlighted strong dividend coverage in the quarter. Article: Q4 2025 Earnings Highlights
• Positive Sentiment: Board declared a quarterly dividend of $0.42 per share (annualized yield ~12.7%), with record date March 31 and payment April 15 — supports income-focused investor demand and signals current cash return commitment.
• Neutral Sentiment: Earnings call transcripts were posted (multiple outlets). These provide more detail on portfolio performance, credit quality and rate sensitivity for investors doing deeper due diligence. InsiderMonkey Transcript Seeking Alpha Transcript
• Neutral Sentiment: Reported short-interest data appears anomalous/zero in the latest report and is unlikely to be a meaningful driver (data error or reporting issue).
• Negative Sentiment: Wells Fargo cut its price target from $14 to $13 and kept an “equal weight” rating — the downgrade reduces near-term analyst support and may pressure sentiment. Article: Wells Fargo price target cut
• Negative Sentiment: Management signaled a review of the dividend and fee structure amid lower base rates — introduces uncertainty about future payout levels or fee income, which can weigh on the BDC’s valuation and income investor confidence. Article: Dividend/fee structure review

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.